I have no doubts the FDA will approve this--they have not put up any "roadblocks" since last April and even agreed to change the trial for the scaffolds from 10 to 5 patients. My understanding is that they needed to tour the Cambridge Mass.to review the manufacturing process and now will okay the trial
Sentiment: Strong Buy